Retour
Également cotée sous
XVIPF
OTC
Fourchette du Jour
6,54 €
6,54 €
Fourchette 52 Semaines
4,25 €
8,74 €
Volume
100
Moyenne 50J / 200J
6,45 €
/
6,45 €
Clôture Précédente
6,54 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 1,2 | 0,3 |
| P/B | 0,1 | 2,9 |
| ROE % | 8,4 | 3,7 |
| Net Margin % | 20,9 | 3,8 |
| Rev Growth 5Y % | 46,2 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,00 €
0,00 € – 0,00 €
|
12 B | 0 |
| FY2026 |
0,00 €
0,00 € – 0,00 €
|
9,1 B | 0 |
Points Clés
Revenue grew 46,23% annually over 5 years — strong growth
Earnings grew 87,52% over the past year
Net margin of 20,94% shows strong profitability
Debt/Equity of 0,02 — conservative balance sheet
Generating 40,56M in free cash flow
P/E of 1,20 — trading at a low valuation
Croissance
Revenue Growth (5Y)
46,23%
Revenue (1Y)37,63%
Earnings (1Y)87,52%
FCF Growth (3Y)N/A
Qualité
Return on Equity
8,40%
ROIC3,02%
Net Margin20,94%
Op. Margin10,74%
Sécurité
Debt / Equity
0,02
Current Ratio4,58
Interest Coverage0,00
Valorisation
P/E Ratio
1,20
P/B Ratio0,10
EV/EBITDA-1,99
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 37,63% | Revenue Growth (3Y) | 40,72% |
| Earnings Growth (1Y) | 87,52% | Earnings Growth (3Y) | 205,68% |
| Revenue Growth (5Y) | 46,23% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 822,42M | Net Income (TTM) | 172,18M |
| ROE | 8,40% | ROA | 7,17% |
| Gross Margin | 74,95% | Operating Margin | 10,74% |
| Net Margin | 20,94% | Free Cash Flow (TTM) | 40,56M |
| ROIC | 3,02% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 4,58 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 1,20 | P/B Ratio | 0,10 |
| P/S Ratio | 0,25 | PEG Ratio | 1,11 |
| EV/EBITDA | -1,99 | Dividend Yield | 0,00% |
| Market Cap | 206,01M | Enterprise Value | -175,47M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 822,42M | 597,54M | 415,29M | 258,39M | 179,86M |
| Net Income | 172,18M | 91,82M | 18,43M | 8,15M | -43,74M |
| EPS (Diluted) | 1,36 | 0,77 | 0,16 | 0,07 | -0,40 |
| Gross Profit | 616,42M | 445,11M | 296,96M | 188,28M | 132,98M |
| Operating Income | 88,35M | 4,19M | 23,18M | 6,98M | -34,31M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 2,40B | 2,20B | 1,73B | 1,54B | 1,15B |
| Total Liabilities | 245,97M | 250,57M | 302,95M | 257,15M | 141,85M |
| Shareholders' Equity | 2,16B | 1,95B | 1,43B | 1,29B | 1,01B |
| Total Debt | 34,04M | 31,44M | 10,01M | 5,72M | 7,21M |
| Cash & Equivalents | 415,52M | 545,79M | 246,55M | 398,70M | 353,44M |
| Current Assets | 813,08M | 826,41M | 467,51M | 547,53M | 463,23M |
| Current Liabilities | 177,51M | 134,49M | 134,90M | 104,52M | 72,25M |
Scores de Stratégies
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026
Entré
Full Throttle
Mar 24, 2026